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Mass spectrometry-based proteomics is increasingly used to address basic and clinical questions in
biomedical research through studies of differential protein expression, protein-protein interactions, and
posttranslational modifications. The complex structural and functional organization of the human brain
warrants the application of high-throughput, systematic approaches to understand the functional alterations
under normal physiological conditions and the perturbations of neurological diseases. This primer focuses
on shotgun-proteomics-based tandem mass spectrometry for the identification of proteins in a complex
mixture. It describes the basic concepts of protein differential expression analysis and posttranslational
modification analysis and discusses several strategies to improve the coverage of the proteome.Introduction
The development of new technology is often a driving force for
new directions in biological research. Proteomics is the study
of the proteins expressed in a specific cell, tissue, or organism
(Wilkins et al., 1996). The availability of genome sequences for
many organisms has generated databases of predicted protein
sequences that are indispensable resources for mass spectrom-
etry-based proteomics. As the in silico analysis of the human
genome has refined the number of genes to 22,000, it is clear
that protein regulation creates functional diversity. The human
body consists of roughly 250 different cell types with different
temporal and spatial protein expression patterns, alternatively
spliced variants, posttranslational modifications (PTMs), and
transient protein-protein interactions. To analyze highly complex
biological samples, a widely used technology is mass spectrom-
etry-based proteomics.
‘‘Shotgun’’ proteomics is a powerful approach for identifying
and quantifying proteins. In this technique, protein mixtures are
converted to peptides by proteolytic digestion, and these
peptides are used as surrogates for identification and quantita-
tion of the proteins present in the original mixture (Figure 1). First,
peptides are fractionated to reduce sample complexity and then
ionized for tandem mass spectrometry analysis (MS/MS). The
ions are mass-selected in the first stage of analysis (MS1), frag-
mented, and the fragmentation ions are analyzed in the second
stage of mass analysis (MS2). The MS2 spectra are searched
against a protein sequence database to identify the amino acid
sequence of the peptides and extrapolate the identities of the
proteins in the sample. The major advantage of shotgun proteo-
mics is its ability to identify and quantify thousands of proteins in
a single analysis.
In this article, we explain the basic principles of mass spec-
trometry, its use in shotgun proteomic analysis of complex
protein samples, and how it has been applied in neuroscience
research. We direct the reader to recent reviews for information
on other useful mass spectrometry-based platforms, including
intact protein or ‘‘top-down’’ analysis (Breuker et al., 2008; Siuti
and Kelleher, 2007), peptide mass fingerprinting (Thiede et al.,
2005), MALDI imaging (Cornett et al., 2007; Wisztorski et al.,12 Neuron 63, July 16, 2009 ª2009 Elsevier Inc.2008), lipidomics (Piomelli et al., 2007), and metabolomics
(Want et al., 2007). Finally, wewould like to emphasis that, before
beginning shotgun experiments in the nervous system,
a researcher must consider the issues of the experimental
design, sample quantity and purity, the large amount of data
that will likely be obtained, and the bioinformatic approaches
that will be used to the analyze the data.
Experimental Design
An important aspect of proteomic experiments is the experi-
mental design. Numerous methods have been developed to
address the needs of specific experiments, and in this section,
we provide a guide to common proteomic experiments. How
an experiment is performed, what controls are used, and what
parameters should be used in data analysis are dependent on
the questions being asked. Sample preparation will depend on
the complexity of the protein mixture. An experiment to measure
changes in protein expression as a result of cell surface receptor
activation requires an approach that covers a large fraction of the
proteome. In contrast, identification of a protein complex does
not require analysis of a highly complex mixture of proteins.
However, shotgun proteomics is not always a preferred
approach. For example, shotgun proteomics is only useful if a
complex is able to be purified to sufficient quantity. If changes
in the expression level of one individual protein are sought and
an antibody is available, shotgun proteomics would not offer
an advantage, but could provide a secondary andmore accurate
means of quantitation.
Sample Requirements
The first question that arises when designing a proteomic exper-
iment is the amount of protein required for MS/MS analysis. A
general rule of thumb is that, if a sample can be detected by silver
stain on a gel (equivalent to a few nanograms of protein), it can be
detected by a mass spectrometer. With MudPIT analysis
(described below), 100 mg total brain homogenate can yield
more than 2000 nonredundant protein identifications (Chen
et al., 2008a). When specific fractions or small brain regions,
such as the synaptosomal fraction or the amygdala, are investi-
gated, the required number of animals increases. Thus, there are
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rial. For example, Nielsen et al. have developed a novel extrac-
tion scheme to comprehensively analyze plasma membranes
from a single mouse hippocampus (Nielsen et al., 2005).
When isolating a specific complex or organelle, the sample
purity is critical. Common copurified abundant proteins can
obscure the identification of components of the targeted
complex or organelle. Before mass spectrometry analysis, the
purity of the complex must be verified by methods such as
western blot analysis or enzymatic assays. Experiments should
also be performed to demonstrate the exclusion of contami-
nants. For example, a nuclear isolation should have greater
immunoreactivity for nuclear markers in western blot analysis
and, just as important, should have a decrease of cytosolic
markers compared to a total lysate. Since MS/MS analysis is
a global analysis, it is a better indicator of sample purity than
many traditional biochemical analyses and may be used to opti-
mize purification methods. If a protein or a group of proteins is
the aim of a study, specific immunological or affinity methods
can be used to enrich and purify the target proteins of interest.
Immunoprecipitation (Ransone, 1995; Lindstrom et al., 2003),
or a more stringent method such as tandem-affinity purification
(TAP) (Rigaut et al., 1999), has made important contributions to
the study of the structure and function of the nervous system
(Chen et al., 2008b; Gottschalk et al., 2005). Such methods
specifically capture the proteins interacting with the target
protein; when combined with shotgun proteomics, they tend to
provide lists of protein identifications with many potential true
targets. A number of nonspecific, contaminant proteins are
also likely to be included. By including a control sample with
the target protein ‘‘knockout,’’ or a nonspecific IgG control in
immunoprecipitation experiments, many contaminants can be
eliminated. In the TAP method, tags are fused in tandem to the
target protein, and the fusion construct is expressed in the
host cells. This two-step affinity-purification procedure not only
greatly reduces contaminant proteins but also allows the effi-
cient elution of the target protein with its interaction partners.
Alternatively, subtractive analysis techniques and stable isotope
labeling (see Quantitation) have been employed to discriminate
between contaminants and true components of the desired
complex (Blagoev et al., 2003; Chu et al., 2006; de Hoog et al.,
2004; Schirmer et al., 2003).
Enzymatic Digestion
Although there are many different proteolytic enzymes available,
trypsin is the most commonly employed. It is highly specific,
cleaving at the carboxyl terminus of arginine and lysine residues.
Since these are abundant residues, almost all proteins of the pro-
teome will possess multiple tryptic peptides. The peptides vary
in length, ranging from a few to greater than 40 residues, aver-
aging 9–10 residues (Elias and Gygi, 2007). One potential
obstacle with the analysis of biological samples is that common
detergents (e.g., triton or SDS), salts, phosphate or sulfate
buffers, and polyethylene glycols are incompatible with mass
spectrometry analysis. They can hinder the enzymatic digestion,
peptide ionization, and chromatography separation (Bosserhoff
et al., 1989; Loo et al., 1994; Vissers et al., 1996). To remove
these contaminants, samples can be precipitated or dialyzed
before MS/MS analysis. To solubilize proteins for enzymatic
digestion, chaotropic agents, usually urea or guanidine hydro-
chloride, are used instead of detergents. The drawback of these
chaotropic reagents is that they can inhibit protease activity at
the concentration required for efficient protein denaturation
and solubilization (Rajagopalan et al., 1961). To overcome this
problem, the concentration of these reagents can be reduced
by dilution before the addition of the protease.
Membrane proteins are underrepresented in most proteomic
analyses unless specific protocols are applied (Speers and
Wu, 2007). One challenge for the analysis of complex mixtures
containing membrane proteins is to maintain solubility through-
out the entire isolation and separation process. To overcome
this difficulty, numerous mass spectrometry-compatible deter-
gents have been developed (Chen et al., 2007). Additionally,
using alternative proteolytic enzymes, such as proteinase
K (Wu et al., 2003) or chymotrypsin (Fischer et al., 2006), or
chemical digestion with cyanogen bromide (Washburn et al.,
2001) aids in the identification of membrane proteins. Further-
more, performing the digestion in the presence of organic
solvents such as acetonitrile or methanol can aid in membrane
Figure 1. Overall Strategy of Shotgun
Proteomics
Tissues or cells are first fractionated, and then the
proteins are solubilized. The protein solution is
digested with a protease, usually trypsin, into
peptides. The digest is fractionated to reduce the
complexity. While the peptides are eluted from
a liquid chromatography column, they are ionized
into the mass spectrometer, and their mass is
determined by a MS1 scan. Ions are further
selected based on their relative abundance for
fragmentation, and a MS2 scan records the
masses of the fragmentation ions. The MS2 spec-
trum is searched against a protein database using
a cluster of computers running in parallel to deter-
mine the peptide sequence and then to identify the
protein.Neuron 63, July 16, 2009 ª2009 Elsevier Inc. 13
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Hervey et al., 2007; Russell et al., 2001; Strader et al., 2006).
To overcome the low abundance of membrane proteins,
membrane-enrichment strategies, including density gradient
centrifugation (Nielsen et al., 2005), colloidal silica affinity
(Rahbar and Fenselau, 2005; Stolz and Jacobson, 1992), and
aqueous-polymer two-phase partitioning (Cao et al., 2006;
Schindler et al., 2006) are used. To remove abundant soluble
proteins and membrane-associated proteins, membrane frac-
tions can be washed with buffers containing high salt. Alterna-
tively, membranes can be incubated in a high-pH buffer followed
by mechanical agitation, which opens membrane vesicles into
membrane sheets, releasing trapped soluble proteins (Howell
and Palade, 1982; Wu et al., 2003). Many of these strategies
require large amounts of starting material. Combining these
enrichment and digestion strategies is the best way to increase
the coverage of low abundant membrane proteins by MS anal-
ysis (Fischer et al., 2006; Nielsen et al., 2005; Speers et al.,
2007). Research is still ongoing to improve the identification of
membrane proteins from complexmixtures, since these proteins
are important drug targets in many human diseases.
Fractionation
Due to the complexity and abundance range of proteins in cells,
fractionation is essential to maximize protein identifications.
Subcellular fractionation of whole-tissue homogenates or iso-
lation of specific protein complexes can reduce sample
complexity and facilitate the identification of low-abundance
proteins. For example, a specific neuronal structure such as
the postsynaptic density (PSD) will be difficult to analyze from
total brain homogenate, but isolation of PSD can reduce the
dynamic range and aid in protein identification. A potential disad-
vantage is that fractionation often requires more starting mate-
rial. Here, we highlight the advantages and disadvantages of
the most popular fractionation techniques. Other peptide-sepa-
ration schemes for mass spectrometry analysis are currently
under investigation (Gilar et al., 2005; Motoyama et al., 2006,
2007; Shen et al., 2002), and it should be noted that there is no
fractionation method that is clearly superior to others for all
experiments and samples.
Fractionation at the Protein Level
Fractionation can be employed at the protein or peptide level.
For shotgun proteomics, an optional protein-fractionation step
precedes peptide fractionation. Various protein-fractionation
techniques have been developed to reduce sample complexity,
including electrophoresis, chromatography, and isoelectric
focusing. Traditional two-dimensional gel electrophoresis fol-
lowed by MS/MS analysis has provided a wealth of information
to neuroscience (Tannu and Hemby, 2006). In this strategy,
digestion of the proteins occurs in the gel, and the peptides
are extracted prior to MS/MS analysis. Contaminants such as
salt and detergents are removed during the procedure, mini-
mizing their interference with MS/MS analysis, but peptides
can be lost during the extraction step (Granvogl et al., 2007).
The molecular weight and isoelectric point of the protein are
known prior to MS/MS analysis, providing increased confidence
for the identification of proteins. In addition, the density differ-
ence between gel spots can provide information regarding rela-
tive protein abundance between samples. The disadvantages14 Neuron 63, July 16, 2009 ª2009 Elsevier Inc.include inefficiency in resolving very large (>200 kD) or very small
(<10 kD), hydrophobic, extremely acidic or basic, and low-abun-
dant proteins. Furthermore, many spots contain more than one
protein, and a partially modified protein can migrate in multiple
spots (Corthals et al., 2000; Fountoulakis et al., 1999a, 1999b;
Gygi et al., 2000; Lim et al., 2003; Molloy, 2000; Oh-Ishi et al.,
2000; Santoni et al., 2000). One-dimensional SDS-PAGE is
also extensively used (Shevchenko et al., 2006), and since
many laboratories routinely perform 1D SDS-PAGE, this tech-
nique can be more accessible than 2D PAGE. Recently, a clever
brain-fractionation method was developed, termed voxelation,
which provides high-resolution spatial proteome mapping
(Petyuk et al., 2007). In this method, the brain is divided into
tiny equal-sized cubes or voxels, which are digested and sub-
jected to peptide fractionation and MS/MS analysis.
Fractionation at the Peptide Level
Although many types of chromatography can be employed to
resolve peptides, reversed-phase (RP) chromatography is the
workhorse for the analysis of peptide mixtures. RP chromatog-
raphy efficiently separates peptides based on their hydropho-
bicity (Aguilar and Hearn, 1996; Sandra et al., 2007). Peptides
are eluted directly from the chromatography column into the
mass spectrometer with an increasing gradient of an organic
solvent, such as acetonitrile (ACN).
If protein fractionation techniques are employed to reduce
sample complexity prior to digestion, then RP chromatography
can be sufficient. If a complex protein mixture (i.e., a synapto-
somal fraction), however, is digested without prior protein
fractionation, it can overwhelm the resolution capability of RP
chromatography by coelution of too many peptides. To meet
the technical challenge of resolving thousands of peptides, the
greater separation power of multidimensional liquid chromatog-
raphy (LC/LC, 2D), proposed initially by Giddings, is employed
(Giddings, 1984). Here, the peak capacity of the system is
a product of the peak capacities of each separation dimension,
provided the coupled separation systems are orthogonal. The
common choice for a second dimension orthogonal to RP is
strong-cation exchange (SCX) to separate peptides based on
charge. Peptides can be fractionated by SCX with increasing
salt concentration, followed by separation of each SCX fraction
on a RP column (Peng et al., 2003). When 2D separation is
directly connected to a mass spectrometer (‘‘online’’), it is called
‘‘multidimensional protein identification technology’’ (MudPIT)
(Figure 2; Yates et al., 1997). The advantage of MudPIT is that,
once a sample is loaded, 100 mg of a protein mixture can be effi-
ciently separated and analyzed in 24 hr without additional
sample handling, resulting in thousands of protein identifica-
tions. One advantage of the offline approach compared to online
analysis is greater tolerance to detergents and salt (Wu and Han,
2006), because peptides separated by SCX can be desalted and
washed extensively to remove incompatible reagents. Isoelec-
tric focusing of peptides has also been used successfully as
the first dimension followed by RP chromatography (Hey et al.,
2008), and recently has been reported to be superior to protein
fractionation via 1D SDS-PAGE followed by RP chromatography
(de Godoy et al., 2008). Overall, these 2D liquid chromatography
methods have greatly increased the number of identifications
from complex protein mixtures.
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There are many different types of mass spectrometers (Domon
and Aebersold, 2006; Payne and Glish, 2005). The fundamental
principle underlying all mass spectrometers is that ion move-
ment can be precisely controlled by an electric or magnetic field,
and the controlled movement of the ions forms the basis for
measuring the mass-to-charge ratio (m/z) of the ion. In general,
mass spectrometers consist of an ion source, mass analyzer,
detector, instrument-control software, and a data-analysis
system. Different combinations of these elements define the
fundamental characteristics of a mass spectrometer, such as
resolution, mass accuracy, and speed. Resolution describes
the ability of a mass spectrometer to distinguish between the
mass of one peptide (M) with another peptide (M + DM). Thus,
the resolution of an instrument is described as M/DM. Mass
accuracy refers to the difference between the measured mass
and the true mass (theoretical mass) and is often noted in parts
per million (ppm). Detecting a 1000 Da peptide to ±0.1 Da can
be described as 1000.00 Da peptide to ±100 ppm. Sensitivity
and the ability to detect ions with a large dynamic range are
also crucial. The dynamic range of the mass spectrometer is
the magnitude between the most and least abundant ions that
can be detected. To achieve high numbers of protein identifica-
tions from complex samples, a mass spectrometer with a fast
scan rate is preferred for a thorough sampling of ions.
For tandem mass spectrometry, a mass spectrometer must
couple two mass analyzers (tandem in space) or be capable of
multiple stages of analysis (tandem in time). Quadrupole-time
of flight (Q-TOF) mass spectrometers are tandem-in-space
instruments that combine a quadrupole mass analyzer with
a TOF mass analyzer. In contrast, ion trap mass spectrometers
are tandem-in-time instruments that perform all stages of anal-
ysiswithin the samemass analyzer. Ion trapmass spectrometers
have a dynamic range of generally three to four orders of magni-
tude. The linear ion trap (LIT) mass spectrometer is sensitive and
possesses the fastest scan rate of any mass spectrometer (i.e.,
one scan in 50 ms), but it collects data at low resolution (2000
M/DM) and low mass accuracy (100–200 ppm). Q-TOF mass
spectrometers are not as fast as LIT, but they have a resolving
powerof6–10,000M/DMandamassaccuracyof10–20ppm.
These two instruments are complementary in the analysis of
a simple protein mixture (Elias et al., 2005).
While the LIT and Q-TOF have been the workhorses in the field
of proteomics, more recent large-scale proteomic experiments
involving quantitation and identification of posttranslational
modifications (PTM) have used high-resolution (>50,000 M/DM)
and accurate mass (2–3 ppm) instruments. Twomass spectrom-
eters with high resolution and mass accuracy are the Fourier
transform ion cyclotron resonance mass spectrometer (FTMS)
(Bogdanov and Smith, 2005) and the orbital trapping (Orbitrap)
mass spectrometer (Hu et al., 2005). Both the FTMS and the
Orbitrap have been used to create hybrid instruments by
coupling to a LIT mass spectrometer, allowing for control over
the ion population injected into the detector and enabling
tandem mass spectrometry experiments (Syka et al., 2004b;
Yates et al., 2006).
Protein Identification
Peptide Fragmentation
In MS/MS, there are two stages of data acquisition (Figure 3A). In
the first stage, all peptide ions injected into the mass spectrom-
eter are analyzed to obtain them/z of each ion species. Themass
spectrum containing this information is called a full scan, survey
scan, or a MS1 spectrum, and the ions are called precursor ions.
In the second stage, ions of interest are often selected based on
the abundance of the ion signal and subjected to fragmentation
by energetic collisions with an inert gas to generate fragmenta-
tion ions or product ions. This fragmentationmechanism is called
collision-induced dissociation (CID) or collision-activated disso-
ciation (CAD). Cleavage occurs at each peptide bond, resulting
in a series of ions differing from each other in mass by the
mass of one amino acid. The m/z of the resulting fragmentation
ions are recorded in the tandem mass spectra or the MS2
spectra. Ions containing the N terminus are termed b ions, and
ions containing the C terminus are termed y ions. Knowing the
residue mass of each amino acid and the m/z of the precursor
ion, the MS2 spectrum can be used to deduce the amino acid
sequence of the peptide (Figure 3B).
Protein Database Searching
Typically, tens of thousands of MS2 spectra can be generated
from a peptide mixture representing hundreds to thousands of
proteins. To transform the enormous amount of MS2 spectra
into the peptide sequence information, automated algorithms to
search the MS2 spectra against protein sequence databases are
Figure 2. Multidimensional Protein
Identification Technology
(A) Peptides are pressure loaded onto a microca-
pillary column containing RP resin (called the
loading column), followed by the analytical column
containing SCX resin connected in tandem with
RP resin filling the column to the 5 mm tip.
(B) Schematic of the two-dimensional liquid chro-
matography protocol. First, the peptides are
eluted to SCX resin upon running ACN through
the column. Next, increasing concentrations of
salt ‘‘bumps’’ are applied to the column, each fol-
lowed by an increasing gradient of ACN. Each salt
bump displaces a discrete portion of peptides
from the SCX and then is separated by the RP in
the analytical column. As the peptides are eluted
from the column, they are ionized by ESI and
directed into the mass spectrometer.Neuron 63, July 16, 2009 ª2009 Elsevier Inc. 15
Neuron
PrimerFigure 3. Tandem Mass Spectrometry
(A) Schematic representation of a tandem mass
spectrometer that operates using tandem by
space, which is exemplified by triple-quadrupole
mass spectrometer. The m/z of the ions is deter-
mined while they are passing through the first
mass analyzer. Ions of a narrow mass window
(e.g., ±0.5 amu) are selected to pass through the
second quadrupole for collision-induced dissocia-
tion (CID), while other ions are rejected. Ions
selected for CID are termed precursor ions. While
theprecursor ions are passing through the collision
cell, they collidewith an inert gas to induce peptide
bond cleavage producing N- and C-terminal frag-
mentation ion series differing by one amino acid
residue. The m/z values of ion series allow the
deduction of peptide sequence.
(B) A MS1 spectrum is shown on the left. The ion
species with an m/z of 731.77 was selected for
CID. The resultingMS2 spectrum for this precursor
ion is shown on the right. Above theMS2 spectra is
the annotated fragmentation ion series. Fragments
containing the C terminus are denoted as y ions,
with the C terminus termed y1 and the C terminus
plus the next residue termed y2, and so forth. Frag-
ments containing the N terminus are denoted as
b ions. The m/z difference between the b or y
ions is the residue mass of an amino acid. In both
spectra, the x axis is the m/z ratio, and the y axis
is the relative abundance.indispensable. Popular database-searching algorithms include
SEQUEST (Eng et al., 1994), Prolucid (Xu et al., 2006), Mascot
(Perkins et al., 1999), X!Tandem (Craig and Beavis, 2004), Spec-
trumMill (Agilent Technologies, Santa Clara, CA, USA), OMSSA
(Geer et al., 2004), and Phenyx (Colinge et al., 2003). For a
complete list of publicly available software tools, detailed reviews
are available (Nesvizhskii et al., 2007; Sadygov et al., 2004).
These algorithms identify potential peptide sequences from
theprotein sequence database based on them/zof the precursor
ion and generate theoretical MS2 spectra based on their amino
acid sequences. An experimental spectrum is compared to these
theoretical spectra to generate a score, and the best-scoring
match is selected as the most likely peptide sequence. The
sequences of the identified peptides from all spectra are then
used to infer the proteins present in the original protein mixture.
Database-searching algorithms employ different methods for
scoring the peptides to determine the best match and differ in
their sensitivities and specificities. Consequently, use of multiple
searching algorithms can increase protein identifications and
help provide added confidence to the protein identifications
(Kapp et al., 2005; Resing et al., 2004).
Confidence in Protein Identifications
A degree of ambiguity can be associated with peptide-spectra
matches. Low-abundance proteins in the sample can generate
MS2 spectra with incomplete sequence ions and high levels of
chemical noise. Posttranslational modifications can affect the
fragmentation pattern, resulting in lower-quality spectra. Finally,
if the sequence information for a protein is not in the database, it
is impossible to obtain a correct sequence assignment. Many of
the spectra fall into this category; a peptide can be assigned for
only 10%–50% of the MS2 spectra collected.
Strategies to determine peptide assignment error and to filter
database search results based on an acceptable error level are16 Neuron 63, July 16, 2009 ª2009 Elsevier Inc.essential. One strategy is to require the identification of two or
more peptides for a protein to be considered identified, because
the probability of a protein being misidentified decreases with
the increased number of peptides identified. Another strategy
is to require a low false-discovery rate (FDR). To estimate the
FDR, both a target protein database and a decoy protein data-
base are searched (Elias and Gygi, 2007). The decoy database
is the target protein database with the sequence of each protein
entry reversed or randomly shuffled. The number of peptide-
spectra matches from the decoy database estimates the FDR
by assuming that incorrect peptide assignments from the target
and decoy databases are equally likely. Although the identities
of the false discoveries are unknown, they tend to be the
sequences with fewer than seven amino acids (Elias and Gygi,
2007). Since lower-abundance proteins are identified by fewer
peptides, there is greater uncertainty in their identification. Con-
sequently, the FDR is always decreasedwhenmore peptides are
required for bona fide protein identification.
Dynamic Range Limits Protein Identifications
MS/MS analysis of a complex peptidemixture is not comprehen-
sive, and the limited dynamic range of the mass spectrometer
precludes collection of the MS2 spectra of all the peptides in
the mixture (Wu and Han, 2006). This results in a semirandom-
ness and a bias in the identification of proteins from complex
mixtures (Liu et al., 2004). Acquisition of MS/MS data is triggered
by the ion-abundance levels, which correspond to the abun-
dance of the peptides in the sample. Usually, the higher-abun-
dance precursor ions in a given MS1 spectra are selected for
fragmentation. Proteins have a large dynamic range; data from
Saccharomyces cerevisiae reveal a range of less than 50 to
more than 106 molecules per cell (Ghaemmaghami et al.,
2003). It has been estimated that shotgun proteomics has
a dynamic range of 104–105 (de Godoy et al., 2008; Wolters
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times by MS/MS analysis, the more-abundant proteins were
identified in each analysis, but the lower the abundance of
a protein, the less frequently it was identified (Liu et al., 2004).
Consequently, replicate analyses of a complex sample can
increase the total number of proteins identified by increasing
detection of lower-abundance proteins.
Quantitation
Label-Free Quantitation
Mass spectrometry can also be used to quantitate differences in
protein expression between samples (relative quantitation). Both
label-free and stable isotope labeling strategies are employed
(for reviews, see Bantscheff et al., 2007; Panchaud et al.,
2008). In general, label-free quantitation methods are inexpen-
sive compared to quantitation using stable isotopes. A simple
and convenient label-free method is spectral count analysis.
The spectral count (SC) for a protein is the number of MS2
spectra assigned to the same protein. The sum of the SC for
all the peptides of one protein is correlated to the abundance
of that protein, which determines the protein’s abundance index
(Gao et al., 2005; Liu et al., 2004). Because the total number of
spectra collected can vary between analyses, the SC of the
protein is normalized. Since MS/MS analysis is skewed to the
identification of highly abundant proteins, it has been suggested
that SC analysis of lower-abundance proteins is unreliable (Col-
inge et al., 2005; Liu et al., 2004; Old et al., 2005). Since SC is only
correlated with protein abundance and is not a direct measure-
ment, this strategy is semiquantitative.
Another label-free strategy is to quantitate the peptides by
measuring the area under the chromatography elution peak for
each peptide or the total ion current of the peptide signal from
the MS1 spectrum (America and Cordewener, 2008), which
indicates the abundance of the peptide in the complex. In
this strategy, the peptide is tracked during the analysis using
itsm/z in the MS1 spectra, and a chromatographic elution profile
of the peptide mass is obtained, which is called an extracted ion
chromatogram (XIC). This method has been reported to be more
accurate than SC analysis (Old et al., 2005), and an advantage of
this technique is that a peptide does not need to be identified in
all samples for it to be quantified. Once a peptide is identified in
one sample, its retention time on the liquid chromatography (LC)
column and its m/z is utilized to search other samples for this
peptide peak. A crucial factor for constructing an accurate XIC
across different samples is the reproducibility of chromatog-
raphy. Fluctuations in the LC system can lead to peptide reten-
tion time shifts, but algorithms have been developed to align
chromatograms by correcting for drift between analyses (Higgs
et al., 2005). To minimize systematic variations in ion current
ratio measurements, peak intensity can be normalized by the
sum or median of ion intensities over the entire analysis (Anderle
et al., 2004).
Stable Isotope Quantitation
The disadvantage of label-free quantitation is that there is no
measure of variation due to sample handling or peptide ioniza-
tion. The use of peptides labeled with heavy stable isotopes
(i.e., 2H, 13C, 15N, or 18O) as internal standards is a common
strategy to prevent these variations from generating quantitationerrors (Conrads et al., 2001; Oda et al., 1999). Peptides labeled
with heavy stable isotopes retain the same biochemical proper-
ties (e.g., retention time) as identical peptides containing natu-
rally abundant or light isotopes, but heavy and light peptides
can be easily distinguished in a mass spectrometer (Figure 4A).
Comparison of the XIC for a light peptide and its corresponding
heavy peptide generates a light/heavy ratio, which can be used
for relative quantitation between samples.
Figure 4. Quantitation with Stable Isotopes
(A) A protein sample was mixed with an identical sample except the proteins
were labeled with 15N. The 14N/15N mixture was then digested and analyzed
on a LIT mass spectrometer. In the MS1 spectrum, two abundant 14N peptides
(630.52 and 944.86) are observedwith the corresponding 15N peptides (638.35
and 958.75). The x axis is them/z ratio, and the y axis is the relative abundance.
(B) Comparison of different strategies to quantify shotgun proteomics experi-
ments. In label-free methods, sample one (S1) and sample two (S2) are never
mixed, allowing systematic errors in quantitation to arise from the numerous
preparation steps. Metabolic labeling allows the mix of samples at the earliest
step in analysis, eliminating variation in sample preparation, while in vitro
labeling strategies, such as ICAT and iTRAQ, control for some, but not all,
possible systematic errors.Neuron 63, July 16, 2009 ª2009 Elsevier Inc. 17
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is how the stable isotopes are incorporated into the peptides.
One strategy is to covalently label proteins or peptides in vitro
with stable isotope reagents such as isotope coded affinity tag
(ICAT) (Gygi et al., 1999) or other similar reagents (Cagney and
Emili, 2002; Schmidt et al., 2005; Wells et al., 2002; Zhang and
Poo, 2002). Some of these reagents only label peptides contain-
ing a specific functional group, however, so only a subset of the
peptides is able to be quantitated. For example, ICAT only labels
cysteine-containing peptides. Alternatively, in the presence of
H2O
18 or H2O
16, trypsin incorporates two labeled oxygen atoms
into every cleaved carboxyl termini (Shevchenko and Shev-
chenko, 2001; Yao et al., 2001). Another in vitro labeling reagent
is iTRAQ, which allows the quantitation of up to eight different
samples simultaneously (Choe et al., 2007). Unlike other
in vitro reagents, the iTRAQ reagents generate identical mass
tags (isobaric tags) by reacting with primary amines (e.g., lysine
side chains and the N terminus). In the MS2 spectrum, each tag
produces a different unique reporter ion at 113, 114, 115, 116,
117, 118, 119, or 121 m/z. The ratio of one reporter ion peak
abundance to another represents the relative amount of a given
peptide in each of the corresponding samples. Since the MS2
spectrum is used, only peptides that are successfully identified
are able to be quantitated. Traditionally, only certain instruments,
such as TOF and triple quadrupole, are capable of resolving ions
in this low m/z region. Recently, an LIT-Orbitrap hybrid mass
spectrometer equipped with higher-energy C-trap dissociation
(HCD) was used to resolve ions in this low m/z region (Olsen
et al., 2007). In addition, iTRAQ-labeled peptides can be
quantitated on a LIT mass spectrometer employing pulse Q
dissociation (PQD) (Griffin et al., 2007).
Although in vitro labeling strategies help measure and control
for variation in peptide ionization, quantitation errors can still
arise from variation in sample fractionation. Stable isotopes
can also be introduced into organisms or cells throughmetabolic
labeling, and overall, this approach is superior to in vitro labeling
for controlling variation between biological samples. However,
in vitro labeling strategies are the only option for quantitative
mass spectrometry analysis of some sample types, such as
those derived from patients. Introducing labels early in the
sample-fractionation process controls for variation in both
sample preparation and peptide ionization and prevents the
accumulation of systematic errors (Figure 4B). Due to the ease
of introducing stable isotope labels into cultured cells, this
method has become popular for metabolic labeling (Chen
et al., 2000; Ong et al., 2002). Multicellular organisms, such as
C. elegans and D. melanogaster, have also been metabolically
labeled with stable isotopes introduced into their food sources
(Krijgsveld et al., 2003). Furthermore, metabolic labeling has
been successfully applied to primary cultured neurons (Liao
et al., 2008b; Spellman et al., 2008). To perform quantitative
analysis on animal models of human disease, two strategies
have been developed. Ishihama et al. employed a metabolically
labeled 15N Neuro2A mouse cell line as an internal standard to
quantify mouse brain proteome (Ishihama et al., 2005). However,
one drawback of this strategy is that the Neuro2A and brain pro-
teomes do not completely overlap. To avoid such problems, the
entire animal can be labeled with heavy isotopes using a method18 Neuron 63, July 16, 2009 ª2009 Elsevier Inc.called stable isotope labeling of mammals (SILAM) (Wu et al.,
2004), in which the rodent is given food with a protein source
enriched with 15N. This technique has been used to quantify
changes in the synaptosomal fraction during postnatal develop-
ment of the cerebellum (McClatchy et al., 2007). Similarly, mice
have been labeled with heavy lysine instead of heavy nitrogen
(Kruger et al., 2008).
Absolute Quantitation
Stable isotopes can also be employed for absolute quantitation
(for a review, see Bronstrup, 2004). In this method, a known
amount of heavy-isotope-labeled peptides is mixed with
a complex peptide sample, and, protein expression is calculated
by comparison to the labeled peptides (Peng et al., 2004). Alter-
natively, labeled proteins can be employed, which provide
a better internal standard than peptides because they can be
added to the sample before fractionation or digestion (Hanke
et al., 2008). For the absolute quantitation of selected proteins
in a complex mixture, triple-quadrupole mass spectrometers
and single reaction monitoring (SRM) assays are often employed
for high sensitivity over a largem/z range (Anderson and Hunter,
2006; Keshishian et al., 2007).
Analysis of Posttranslational Modifications
Mass spectrometry has a unique advantage in the analysis of
PTMs since it directly measures the m/z of peptide ions and, in
principle, is capable of detecting anymass shift due to a chemical
modification. If themass of the PTMof interest is known, the user
only needs to search the MS2 spectra with the mass shift of the
precursor ion. For example, a single phosphorylation of a peptide
results in a mass gain of 79.9663 amu on serine, threonine, or
tyrosine residues (Figure 5), and a database search needs to
consider the possibility that each one of the residues is modified.
Twomain obstacles persist for analyzing modified peptides from
complex mixtures using MS/MS. First, the stoichiometry of the
modified versus unmodified protein species is often low, and
thus, enrichment strategies are required before MS/MS analysis.
Second, PTMs can cause the fragmentation pattern to be less
informative than unmodified peptides, hindering peptide identifi-
cation and/or explicit identification of the modification site.
Several strategies have been developed to overcome these
obstacles, which are specific to the PTM being studied. Recent
reviews discuss the analysis of specific PTMs: phosphorylation
(Paradela and Albar, 2008), glycosylation (Zaia, 2008), and ubiq-
uitination (Peng, 2008).
Here, we review some of the common strategies for the anal-
ysis of phosphorylation by shotgun proteomics. One approach
for phosphopeptide enrichment involves the covalent coupling
of phosphorylated serine (pSer) and threonine (pThr) by removal
of the phosphoric acid moiety through b-elimination followed by
Michael addition of nucleophilic groups, such as biotin or fluo-
rous affinity tags (Brittain et al., 2005; Klemm et al., 2004). The
coupled reactive group can facilitate further affinity enrichment
(Jalili and Ball, 2008) and the localization of phosphorylation
sites. A popular enrichment strategy is immobilized metal ion
affinity chromatography (IMAC), where phosphorylated peptides
or proteins are enriched through a chelating reaction between
metal ions (Fe3+, Ga3+) and the phosphate group (Andersson
and Porath, 1986). Metal oxides (TiO2, ZrO2) have also been
Neuron
Primerused for phosphopeptide enrichment (Kweon and Hakansson,
2006; Larsen et al., 2005) and appear to be more selective
than IMAC for simple mixtures (Cantin et al., 2007; Larsen
et al., 2005). Recently, metal-oxide-based nanoparticles have
been used with better specificity than IMAC (Chen and Chen,
2005; Tan et al., 2008). Another enrichment method employs
either SCX or strong anion exchange (SAX) chromatography to
separate the sample into multiple fractions and reduce sample
complexity. Phosphopeptides are enriched in early eluates in
SCX and in late fractions in SAX (Han et al., 2008; Villen et al.,
2007). These strategies efficiently enrich for peptides containing
phosphoserine and phosphothreonine, but antibodies are
preferred to selectively enrich phosphotyrosine-containing
peptides (Munton et al., 2007; Olsen et al., 2006; Villen et al.,
2007). In general, antibodies against phosphotyrosine have
good specificity and quality (Rush et al., 2005). Finally, different
phosphorylation enrichment strategies are complementary,
and no single method is capable of analyzing a phosphopro-
teome comprehensively (Bodenmiller et al., 2007).
Phosphoester bonds at serine, threonine, and to a lesser
extent at tyrosine are more labile than the peptide backbone
during CID, which results in the neutral loss of phosphoric acid
(Beausoleil et al., 2004; DeGnore and Qin, 1998) and hampers
confident identification of phosphopeptides since this neutral
loss fragmentation pattern yields fewer fragment ions. Without
a complete series of fragmentation ions, precise phosphoryla-
tion site localization is ambiguous when multiple serine, threo-
nine, and tyrosine residues exist within a single peptide. To
further increase the confidence in phosphopeptide identifica-
tions, several algorithms have been developed to validate phos-
phopeptide identifications derived from the MS2 spectra. One
such algorithm, Debunker, derives a probability score for phos-
Figure 5. Analysis of Protein Phosphorylation
Similar to shotgun analysis of unmodified proteins, phosphoproteins are
digested with trypsin. The addition of a phosphate group on a serine, threo-
nine, or tyrosine residues in a peptide results in an addition of mass 79.9663
amu on the peptide precursor ions. As shown in theMS1 spectra, the precursor
ion 550.24 is the charge 2 ion of the peptide MPFQADPGGK (m/z 510.25) con-
taining a phosphate group, which can be further identified through MS/MS.phopeptide identifications from the MS2 spectra by analyzing
prominent spectra features characteristic of phosphopeptides
(Lu et al., 2007). MS/MS/MS (MS3) strategies have taken advan-
tage of this neutral loss phenomenon to improve the identifica-
tion of phosphopeptides (Beausoleil et al., 2004; Steen et al.,
2001). In the MS3 strategy, the neutral loss ion (the precursor
ion without phosphoric acid) is selected for further fragmenta-
tion, resulting in a more informative fragmentation pattern and
higher-quality identification of the phosphopeptides (Beausoleil
et al., 2004).
Two other fragmentation methods have been explored to
improve the peptide fragmentation by preserving the PTM on the
peptide since complete or near-complete fragment ions in
the MS2 spectra can dramatically improve the confidence of
the peptide identification. Electron capture dissociation (ECD)
involves exposure of protonated peptide ions to electrons con-
taining near-thermal energy, producing radical cations that
readily fragment to generate a complete spectrum of ions with
the modification intact (Zubarev et al., 2000). Unfortunately, for
commonly used mass analyzers (including the LIT and the
Q-TOF), it is difficult to maintain the thermal electrons in the colli-
sion cell long enough to allow the capture of the electrons by
protonated peptides, so this strategy is restricted to a FTMS.
Electron transfer dissociation (ETD) is an alternative approach
that can be implemented in LIT mass spectrometers (Schroeder
et al., 2005; Syka et al., 2004a). In ETD, anions are used to trans-
fer electrons onto protonated peptides, triggering the release of
hydrogen radical and dissociation of peptides by a mechanism
similar to ECD.
Bioinformatics
Now that hundreds to thousands of proteins have been identi-
fied, what do you do with all this data? Bioinformatic analysis
of the data is a critical step of proteomic research, yet is often
overlooked when designing proteomic experiments. Before col-
lecting data, the bioinformatics analyses that will be used to
interpret the data should be chosen, and this is not a trivial
task, for there is an almost infinite number of ways to analyze
the data. A clear hypothesis will aid the researcher in the bioinfor-
matics analysis. For example, testing the hypothesis that
proteins regulating protein folding are altered in different ages
of an Alzheimer’s disease mouse model will focus the analyses
on a subset of the thousands of proteins that were identified in
the experiments. Here, we describe data analyses that are
commonly employed in proteomic experiments, and this section
is not meant to be an exhaustive review. An excellent resource to
generate ideas for data analysis of large data sets are published
microarray reports, because many of the analyses employed in
these studies are directly applicable to proteomic analyses.
Quantitation in a proteomic experiment is useful for detecting
the proteins altered in an experiment. With quantitated MS/MS
data, the first decision is the threshold to be employed to deter-
mine an actual change in protein expression. Numerous proteo-
mic reports have chosen arbitrary cutoffs. For example, greater
than 2-fold changes in replicate experiments is generally consid-
ered as a ‘‘true’’ change in protein expression. Nevertheless,
statistical analyses (i.e., Student’s t test or ANOVA) will ensure
more confidence in the observed changes. The experiment,Neuron 63, July 16, 2009 ª2009 Elsevier Inc. 19
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applied to the data. This often entails biological replicate anal-
yses where the minimum sample number equals three. When
biological replicates are not accessible, the statistical analysis
can be performed on one set of biological samples using each
peptide quantitated for a protein as one measurement. This
type of statistical analysis was successfully performed on synap-
tosomal preparations from the cerebellum at different develop-
mental time points (McClatchy et al., 2007). For example,
a protein is quantitated by six peptides at time point 1 and is
quantitated by eight peptides at time point 2. Statistical analysis
with uneven number of samples can be performed and allows
the identification of significant alterations in the data set. Further
functional analyses can focus on proteins with significant
changes between biological conditions.
Another important stage of data analysis is annotation,
which is often performed with GeneOntology (GO) designations
(http://www.geneontology.org). GO is a controlled vocabulary
describing a gene by three categories: localization, molecular
function, and biological function. The majority of proteins
possess multiple terms within each category, and as a result,
there are caveats to how precise GO analysis can be. Only
a percentage of the proteomic data set can be annotated,
because the genes for some proteins are unknown, and all genes
for all species have yet to be annotated. GO terms are derived
from a consensus of voluntary curators, which every scientist
may not agree with, and as knowledge of the proteins change,
updates will often lag behind.
In the last 5 years, there has been an explosion of free and
commercially available software to annotate proteomic data
sets and perform pathway analysis. Some widely used free soft-
ware programs include KEGG (Kanehisa and Goto, 2000), Bio-
Carta (http://biocarta.com/), GenMAPP (Dahlquist et al., 2002),
and Cytoscape (Shannon et al., 2003). In general terms, pathway
analysis computes the probability that the proteins in the data set
match an annotated pathway. An advantage of these programs
is that they include pathways specific to human disease, which
are absent in the GO terms. Many of these programs, however,
are dominated bymetabolic processes, butmore signaling path-
ways are currently being annotated, including brain-specific
pathways. Finally, clustering analysis is a helpful data-mining
procedure that can be performed on annotated and unannotated
proteins. Cluster analysis is an exploratory data-analysis tool
that sorts proteins into groups in a way that the degree of asso-
ciation between two objects is maximal if they belong to the
same group andminimal otherwise. For example, if a quantitative
proteomic experiment is composed of four time points, cluster
analysis can be used to identify proteins that have similar
temporal trends. Cluster is a popular and free program for these
analyses (http://rana.lbl.gov/EisenSoftware.htm).
Application of Shotgun Proteomics in Neuroscience
As with many new techniques, shotgun proteomics has been
used extensively with simpler biological systems. Nevertheless,
the application of shotgun proteomics to neuroscience research
is steadily increasing. Here, we discuss several studies that high-
light the potential of shotgun proteomics for addressing key
questions in neuroscience research.20 Neuron 63, July 16, 2009 ª2009 Elsevier Inc.Dissection of Protein Components
Large-scale identification is well suited to identify individual
components of a defined neuronal structure or a protein-protein
interaction complex. Many proteomic analyses of the postsyn-
aptic density (PSD) have been reported. Initially, 1D PAGE
combined with MALDI-TOF mass spectrometry to identify 31
proteins from a PSD preparation (Walikonis et al., 2000). Over
the past several years, identification of the protein components
of the PSD has been expanded at a dramatic pace due to
improvements in chromatographic separation, instrument sensi-
tivity, and database searching (Jordan et al., 2004; Li et al., 2003;
Peng et al., 2004; Yoshimura et al., 2004). The most comprehen-
sive analysis combined MS/MS analysis of the PSD with MS/
MS analysis of the immunopurified N-methyl-D-aspartic acid
(NMDA) receptor complex, the a-amino-3-hydroxyl-5-methyl-
4-isoxazole-propionate (AMPA) receptor complex, and the
membrane-associated guanylate kinase (MAGUK) complex. In
addition, the PSD data were integrated with six published pro-
teomics data sets to estimate a total of 1124 PSD proteins,
466 of which were identified in at least two proteomic studies
(Collins et al., 2006). Several methodological differences can
contribute to the low reproducibility between studies, including
animal strain, brain region being analyzed, protein and peptide
fractionation techniques, mass spectrometers used, and data-
base searching algorithms. The identified PSD proteins have
diverse cellular functions, such as signaling, scaffolding, trans-
lation, and transcription, and more than 10% of the identified
proteins are novel. Nuclear proteins have also been localized
to the PSD (Jordan et al., 2004; Moon et al., 1999), but it is
unclear whether these proteins possess novel functions at the
synapse, raising the question of the purity of these PSD prep-
arations. A subtractive proteomic experiment, which has yet to
be reported, is suitable to address this issue. For example,
comparison of protein abundances between a PSD preparation
and total brain homogenate with stable isotope labeling would
suggest bona fide PSD proteins based on their quantitative
enrichment in the PSD. Proteomics approaches hold similar
promise for the examination of other nervous system struc-
tures. For example, shotgun proteomics was used to analyze
purified hair cell bundles of the inner ear, leading to the identi-
fication of creatine kinase as a key molecule in energy homeo-
stasis during auditory mechanosensory transduction (Shin
et al., 2007).
To identify members of protein complexes, other studies start
with immunoprecipitation with specific antibodies or affinity puri-
fication of tagged proteins to isolate protein components that
interact with a protein of interest. For example, to study the
role of the ATP-dependent chromatin remodeling complex
SWI/SNF-like during brain development, antibodies against the
ATPases Brg and Brm were used to purify the complex from
newborn mouse brain, and the isolated complexes were sub-
jected to MS/MS analysis (Lessard et al., 2007). Four proteins
(BAF45a, BAF45b, BAF45c, and BAF45d) that were not previ-
ously known to be the components of the SWI/SNF-like complex
were identified. Further analysis established that BAF45a and
BAF53a are essential for maintaining neural stem/precursor
cell self-renewal and proliferation, while BAF45b, BAF45c, and
BAF53b are required to acquire neuronal properties, leading to
Neuron
Primerthe conclusion that a switch in subunit composition accom-
panies the transition from neural stem cells to differentiated
neurons. Another study addressed how neuronal excitability is
controlled by the G protein-gated potassium channel Kir3
(Lunn et al., 2007). Proteins that interact with the C-terminal
domain of Kir3 were isolated from rat brain homogenate, and
shotgun analysis uncovered sorting nexin 27 (SNX27) as
a specific and abundant interacting partner of Kir3. Functional
analysis revealed that SNX27 regulates the inhibitory current
mediated by Kir3 by downregulating its surface expression via
increased endosomal trafficking, representing a novel mecha-
nism for controlling surface expression of ion channels.
Protein Dynamics
MS/MS analysis can also provide insight into the dynamics of
biological processes. For example, Moron et al. quantitated
changes in the hippocampal PSD after morphine administration
with ICAT labeling to assess the molecular changes underlying
the effects of opiates on synaptic plasticity (Mansouri et al.,
1997; Pu et al., 2002). The endocytic protein clathrin showed
the largest increase upon morphine treatment. After morphine
treatment, the association between clathrin and the homer
protein increased, while the association between clathrin and
the AMPA receptor GluR1 decreased at the PSD, suggesting
that morphine treatment results in decreased GluR1 internaliza-
tion. A similar study applied iTRAQ on synaptic membrane frac-
tion to identify changes in the medial prefrontal cortex after
cue-induced relapse to heroin seeking. The authors discovered
that reintroduction of the cues previously associated with
heroin correlated with downregulation of AMPA receptor
subunit GluR2 and upregulation of clathrin-coat assembly
protein AP2m1. Subsequent experiments lead to the conclu-
sion that GluR2 receptor endocytosis and the resulting synaptic
depression might be the cause of cue-induced heroin relapse
(Van den Oever et al., 2008). Together, these studies revealed
that opioid induces synaptic plasticity through glutamate
receptor endocytosis, suggesting new ways to manage opioid
addiction.
Dynamic protein turnover at synapse, including protein sort-
ing, transport, and local protein synthesis, is thought to underlie
the long-lasting changes in synaptic strength (Steward and
Schuman, 2003; Sutton and Schuman, 2005). RNA transport
from the cell body to the distal dendrites and axons is the prere-
quisite for local protein synthesis. Elucidating the composition
of the protein machineries responsible for these important
processes is difficult by other methods, while shotgun-proteo-
mics-based discovery can directly shed light on these questions.
Two studies used either an affinity pull-down or density gradient
centrifugation approach to isolate an RNA transporting granule
from rodent brain, followed by protein identification using mass
spectrometry. The studies confirmed that the granules are trans-
ported through kinesin and identified the protein components
of the granule: RNA-transport proteins, protein-synthesis
machinery, and regulators for translation (Elvira et al., 2006; Ka-
nai et al., 2004). Combined with an imaging study, the results
shed light on howmotor proteins transport RNAs. Another study
used an elegant cell-culture method to purify axons from dorsal
root ganglion neurons and applied proteomic methodology to
identify proteins synthesized at axons (Willis et al., 2005).Posttranslational Modifications
Phosphorylation plays crucial roles in the development and regu-
lation of the central nervous system. To date, the application of
shotgun proteomics to analyze protein phosphorylation has
been extended into many areas of the nervous system, including
regulation of synaptic transmission through the activation of
kinases and phosphatases (Munton et al., 2007; Trinidad et al.,
2008), glutamate receptor signaling, and neural development
(Ballif et al., 2004; Liao et al., 2008a), as well as neurological
disorders (Zhou et al., 2008). While the focus has been on
large-scale identification of phosphopeptides and phosphoryla-
tion sites, an emerging trend is the quantitation of phosphoryla-
tion changes under different biological conditions. For example,
Munton et al. analyzed changes in the phosphorylation of PSD
components after potassium chloride stimulation of synapto-
somes. They discovered an activity-dependent, isoform-specific
phosphorylation of Ca2+/calmodulin-dependent protein kinase II
and measured the phosphorylation stoichiometry of a novel
activity-dependent phosphorylation site on GluR1 that has
subsequently been shown to have a potential role in long-term
potentiation (Delgado et al., 2007).
Phosphorylation analysis is also often performed on an indi-
vidual protein. For example, based on prior reports that the
suppression of neuronal firing by the potassium channel Kv2.1
depends upon its dephosphorylation by the protein phosphatase
calcineurin, Park et al. sought to identify the relevant phosphor-
ylation sites. They identified 16 sites, seven of which were phos-
phorylated in the rat brain and dephosphorylated by calcineurin.
Mutagenesis analysis revealed that these sites are functionally
additive, indicating that variable phosphorylation events allow
for a graded regulation of channel gating (Park et al., 2006).
The analysis of other modifications has led to unexpected
findings. For example, Khidekel et al. combined chemical deriv-
atization, isotopic chemoenzymatic tagging, and quantitative
proteomics to analyze b-N-acetyl-D-glucosamine modification
in proteins (O-GlcNAc glycosylation). Facilitated by ETD to
precisely localize the modification sites, they discovered new
glycosylated O-GlcNAc proteins and identified dynamic regula-
tion of O-GlcNAc glycosylation of proteins upon excitatory
neuronal stimulation (Khidekel et al., 2007). Protein palmitoyla-
tion has recently been recognized to have important functional
implications in protein trafficking in neurons. Kang et al. applied
acyl-biotin exchange (ABE) chemistry to selectively purify palmi-
toylated proteins from cultured rat neurons and synaptosomal
membrane fractions. After MudPIT analysis, the authors identi-
fied the majority of known neural palmitoyl proteins and
expanded the new pool of palmitoylated proteins by over 200.
Focusing on the synaptic function of a Cdc42 splice variant after
palmitoylation, the authors suggest that palmitoylation may play
a broad role in activity-dependent synaptic morphological
changes (Kang et al., 2008).
Finally, phosphorylation, ubiquitination, and other modifica-
tions have been implicated in many neurological disorders,
including Alzheimer’s, Parkinson’s, and Huntington’s diseases
(Geschwind, 2003; Chen and Feany, 2005; Shimura et al.,
2000; Valera et al., 2005), and they have become the target of
many proteomic analyses. Mass spectrometry has been used
to identify and analyze phosphorylation sites on the insolubleNeuron 63, July 16, 2009 ª2009 Elsevier Inc. 21
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tissue. Combined with kinase assays, they assigned casein
kinase 1d and glylcogen synthase kinase 3b as the predominant
kinases for serine/threonine phosphorylation of tau (Hanger
et al., 2007). Bennett et al. evaluated the endogenous ubiqui-
tin-proteosome system (UPS) function in Huntington’s disease.
They used quantitative mass spectrometry to monitor global
changes in polyubiquitin conjugations after capture of polyubi-
quitin chain using ubiquitin-association domain. The authors
discovered that lysine 48 linked polyubiquitin chain accumulated
early in brains of two models of Huntington’s disease (HD), as
well as in brains of HD patients (Bennett et al., 2007). Lysine
6 and 11 linked polyubiquitin chains also increased in the HD
mouse brain. This study provides in vivo evidence that UPS
impairment is an early event accompanying HD pathogenesis.
Conclusions
Shotgun proteomics has been proven to be a driving force in
neuroscience research. The advantage of analyzing thousand
of proteins in a single experiment has led to the novel identifica-
tion of proteins involved in brain function and provided unique
insight into the nervous system.
However, there are still limitations to this technique. Foremost,
the dynamic range of protein concentrations within a cell is
beyond the intrinsic capability of any currentmass spectrometer.
Further, the identification of peptides by database-searching
algorithms is limited due to PTMs and alternative splicing. It has
been estimated that there are over 300 PTMs in the human pro-
teome (http://abrf.org/index.cfm/dm.home?AvgMass=all) and
that at least 80% of genes are alternatively spliced (Pan et al.,
2008; Wang et al., 2008). If these PTMs are not directly searched
for or these alternative spliced products are not in the database,
these peptides will remain unidentified. Many proteomic labora-
tories are currently investigating new bioinformatic, chromato-
graphic, separation, and mass spectrometry techniques to
surpass these obstacles and extract more information from
smaller amounts of proteins. By using the strides made toward
this goal in the last 5 years as an indicator, shotgun proteomics
will continue to be a valuable tool for neuroscientists.
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